Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Margaritis Schinas and Adrian Van Den Hoven visited ELPEN

15 November 2021

Open

Access to medicines critical in European Parliament vote on EU IP action plan

12 November 2021

The European Parliament Own Initiative Report on an intellectual property […]

Read more

IGBA Calls on all Stakeholders to Join the Biosimilars Movement on Advancing Access

1 November 2021

Open

European Commission pilot project on repurposing brings value added innovation to life

28 October 2021

Innovation on existing, well-known molecules through repurposing can deliver huge benefits for patients and address unmet medical needs sustainably. Today […]

Read more

Digitalisation the key to efficient EU pharmaceutical regulation and easing of localised drug shortages

27 October 2021

“Digitalisation the key to efficient EU pharmaceutical regulation and easing […]

Read more

“Central Role For Industry Beckons As Europe Rebuilds After COVID” – Interview to Rebecca Guntern

25 October 2021

Generics And Biosimilars Must Become A Central Policy Pillar, Says […]

Read more

Smart use of off-patent medicines will be critical to rebuild healthcare systems successfully post-Covid

7 October 2021

Open

Baton passes from Christoph Stoller to Rebecca Guntern as President of Medicines for Europe

1 October 2021

Rebecca Guntern (Sandoz) today begins an interim term as President […]

Read more

HERA must address outstanding weaknesses in EU pharma framework to be successful

16 September 2021

Medicines For Europe strongly supports the EU’s drive to learn from COVID-19 […]

Read more

Arun Narayan, Chairman of the Value Added Medicines Sector Group interviewed by the European Pharmaceutical review

8 September 2021

Open

Subscribe to our newsletter